Pneumococcal conjugate second or third-dose vaccines (PCVc) in Yemen
Yemen: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 39.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Yemen, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Yemen recorded 39.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025.
That represents a change of down 4.9% on the previous year and down 38.1% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Yemen peaked at 71.0% in 2013 and was at its lowest, 0.0%, in 2008.
That places Yemen 160th out of 194 countries with data for 2025, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Yemen, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 41.0% | — |
| 2012 | 67.0% | +63.4% |
| 2013 | 71.0% | +6.0% |
| 2014 | 69.0% | -2.8% |
| 2015 | 63.0% | -8.7% |
| 2016 | 62.0% | -1.6% |
| 2017 | 58.0% | -6.5% |
| 2018 | 51.0% | -12.1% |
| 2019 | 58.0% | +13.7% |
| 2020 | 55.0% | -5.2% |
| 2021 | 55.0% | +0.0% |
| 2022 | 57.0% | +3.6% |
| 2023 | 45.0% | -21.1% |
| 2024 | 41.0% | -8.9% |
| 2025 | 39.0% | -4.9% |
Yemen compared with similar countries
- Yemen's 39.0% is below the median for low income countries, which is 80.0%, 49% of the median. (25 countries reporting)
- Yemen's 39.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 91.0%, 43% of the median. (23 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Yemen changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2012 | +63.4% | 41.0% | 67.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 54.0% | 0.0% | 71.0% | 10 |
| 2020s | 48.7% | 39.0% | 57.0% | 6 |
Countries ranked near Yemen
- 158 Central African Republic 45.0% compare
- 159 Papua New Guinea 44.0% compare
- 160 Haiti 39.0% compare
- 162 Montenegro 28.0% compare
- 163 South Sudan 27.0% compare
More health data for Yemen
- Un projection of annual infant deaths, annual growth rate -1.94 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.04 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 809.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 9,603 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 103 (2025)
- Population ages 00-04, female, annual growth rate 1.88 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2018)
- Population ages 00-04, female, per capita 0.0766 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.89 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2018)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Yemen?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Yemen was 39.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Yemen?
- The highest recorded value was 71.0% in 2013.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Yemen?
- The lowest recorded value was 0.0% in 2008.
- How does Yemen rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Yemen ranks 160th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Yemen?
- Over the last ten years it is down 38.1%. The long-run trend across the full record is rising.
- Where does this Yemen data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).